myriamed Competitors and Similar CompaniesClear all

myriamed's competitors and similar companies include KNOW Bio, The Searle Company, CSL and Shandong Saito Biotechnology.

	myriamed myriamed is a company that focuses on heart and skeletal muscle.	KNOW Bio KNOW Bio is a life science company that specializes in nitric oxide and precision light therapy.	The Searle Company The Searle Company is a pharmaceutical company.	CSL CSL is a biotech company providing life-saving medicines.	Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
Founding Date	Founding Date 2012	Founding Date 2015	Founding Date 1965	Founding Date 1916	Founding Date 2010
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare accelerator biotech drug development	Tags Healthcare accelerator biotech drug development private equity therapy	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development
Locations	Locations Göttingen, DE HQ	Locations Durham, US HQ	Locations Karachi, PK HQ Karachi, PK Karachi, PK Lahore, PK	Locations Parkville, AU HQ King Of Prussia, US	Locations Heze, CN HQ
Employees	Employees 7	Employees 8	Employees 2,4241% increase	Employees 32,698	Employees 95920% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 95.1 b	Valuation ($) 708.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $15.4b (FY, 2025)	Revenue (est.) ¥961.3m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $6.5b (FY, 2025)	Cost of goods ¥864.3m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $9.1b (FY, 2025)	Gross profit ¥140.3m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income $3.1b (FY, 2025)	Net income (¥84.7m) (FY, 2025)